Literature DB >> 31943616

Evidence-poor medicine: just how evidence-based are Australian clinical practice guidelines?

Cameron Venus1,2, Euzebiusz Jamrozik2.   

Abstract

BACKGROUND: Clinical practice guidelines aim to assist medical practitioners in making efficient evidence-based decisions in daily practice. However, international studies have shown that the majority of recommendations in American and European guidelines are not based on strong evidence. AIMS: To review Australian clinical practice guidelines across a broad range of high-impact conditions and determine how evidence-based they are.
METHODS: Australian guidelines published from January 2010 to May 2018 relating to the top 10 causes of death in Australia were identified from the National Health and Medical Research Council (NHMRC) clinical practice guideline database and other relevant sources. The graded recommendations in these guidelines were extracted for analysis and the systems used for grading the recommendations were recorded.
RESULTS: Ten relevant Australian guidelines were identified, containing a total of 748 graded recommendations. All 10 guidelines used either the Grading of Recommendations Assessment, Development and Evaluation (GRADE) or NHMRC systems to assess recommendations. However, only 18% (n = 136) of these recommendations were based on Level I (or equivalent) evidence; 25% (n = 185) were based on Level II evidence, 29% (n = 218) on Level III, and 9% (n = 66) on Level IV. Consensus-based recommendations accounted for 19% (n = 143) of all recommendations.
CONCLUSIONS: Despite the enthusiasm of the evidence-based medicine movement and its documented successes, contemporary medicine appears to remain largely evidence-poor, not evidence-based. Future research should aim to provide reliable descriptions of what constitutes valid clinical reasoning in evidence-poor situations.
© 2020 Royal Australasian College of Physicians.

Entities:  

Keywords:  clinical practice guideline; clinical reasoning; evidence-based medicine; evidence-poor medicine; medical decision-making

Year:  2020        PMID: 31943616     DOI: 10.1111/imj.14466

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  Embedding clinical trials within routine health-care delivery: Challenges and opportunities.

Authors:  Annaleise R Howard-Jones; Steven A Webb
Journal:  J Paediatr Child Health       Date:  2021-03-03       Impact factor: 1.929

2.  Broad Medical Uncertainty and the ethical obligation for openness.

Authors:  Rebecca C H Brown; Mícheál de Barra; Brian D Earp
Journal:  Synthese       Date:  2022-04-10       Impact factor: 2.908

3.  Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.

Authors:  Geertruida Bekkering; Nicolas Delvaux; Patrik Vankrunkelsven; Jaan Toelen; Sigrid Aertgeerts; Sofie Crommen; Pedro De Bruyckere; Ignaas Devisch; Tinne Lernout; Katrien Masschalck; Nore Milissen; Geert Molenberghs; Annelies Pascal; Oscar Plomteux; Marc Raes; Lise Rans; Alexandra Seghers; Lode Sweldens; Jeroen Vandenbussche; Guido Vanham; Elke Wollants; Bert Aertgeerts
Journal:  BMJ Paediatr Open       Date:  2021-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.